QuidelOrtho annual free cash flow
2020
2021
2022
2023
2024
2025
QuidelOrtho Free Cash Flow (FCF) History (QDEL)
QuidelOrtho reported −$83.0M in free cash flow for fiscal 2025, an increase of $29.1M from the previous fiscal year, with a free cash flow margin of −3.04%.
View full QuidelOrtho company overviewQuidelOrtho free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-28 | −$83.0M | $29.1M | — | −3.04% |
| 2024 | 2024-12-29 | −$112.1M | −$183.0M | — | −4.03% |
| 2023 | 2023-12-31 | $70.9M | −$673.5M | −90.48% | +2.37% |
| 2022 | 2023-01-01 | $744.4M | $231.3M | +45.08% | +22.79% |
| 2021 | 2022-01-02 | $513.1M | −$51.7M | −9.15% | +30.21% |
| 2020 | 2021-01-03 | $564.8M | — | — | +33.99% |
QuidelOrtho quarterly free cash flow
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-28 | −$136.1M | −$51.8M | — | −21.57% |
| Q1 2026 | 2026-03-29 | −$67.0M | −$76.4M | — | −10.81% |
| Q4 2025 | 2025-12-28 | $86.6M | $70.1M | +424.85% | +11.97% |
| Q3 2025 | 2025-09-28 | −$94.7M | −$166.1M | — | −13.53% |
| Q2 2025 | 2025-06-29 | −$84.3M | $48.9M | — | −13.73% |
| Q1 2025 | 2025-03-30 | $9.4M | $76.2M | — | +1.36% |
| Q4 2024 | 2024-12-29 | $16.5M | −$15.3M | −48.11% | +2.33% |
| Q3 2024 | 2024-09-29 | $71.4M | $73.3M | — | +9.82% |
| Q2 2024 | 2024-06-30 | −$133.2M | −$51.3M | — | −20.91% |
| Q1 2024 | 2024-03-31 | −$66.8M | −$189.7M | — | −9.40% |
| Q4 2023 | 2023-12-31 | $31.8M | −$75.9M | −70.47% | +4.28% |
| Q3 2023 | 2023-10-01 | −$1.9M | $38.3M | — | −0.26% |
| Q2 2023 | 2023-07-02 | −$81.9M | −$280.4M | — | −12.31% |
| Q1 2023 | 2023-04-02 | $122.9M | −$355.5M | −74.31% | +14.53% |
| Q4 2022 | 2023-01-01 | $107.7M | $137.6M | — | +12.43% |
| Q3 2022 | 2022-10-02 | −$40.2M | — | — | −5.13% |
| Q2 2022 | 2022-07-03 | $198.5M | — | — | +32.36% |
| Q1 2022 | 2022-04-03 | $478.4M | — | — | +47.73% |
| Q3 2021 | 2021-10-03 | −$29.9M | — | — | −5.87% |
QuidelOrtho free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $564.8M to −$83.0M, a net decrease of $647.8M. QuidelOrtho's latest reported quarter, Q2 2026, generated −$136.1M in free cash flow, a decrease of $51.8M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review QuidelOrtho filings at SEC.gov ↗